within Pharmacolibrary.Drugs.N_NervousSystem.N02A_Opioids.N02AF02_Nalbuphine;

model Nalbuphine
  extends Pharmacolibrary.Drugs.ATC.N.N02AF02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N02AF02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Nalbuphine is a synthetic opioid analgesic used to treat moderate to severe pain. It acts as a mixed agonist-antagonist at opioid receptors—agonist at kappa-opioid receptors and antagonist at mu-opioid receptors. It is primarily approved for use in the management and relief of pain, pre- and postoperative analgesia, and as a supplement to balanced anesthesia. It is currently approved for medical use in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Pfiffner, M, et al., &amp; Berger-Olah, E (2023). Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants. <i>Archives of disease in childhood</i> 108(1) 56–61. DOI:<a href=\"https://doi.org/10.1136/archdischild-2022-323807\">10.1136/archdischild-2022-323807</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36100355/\">https://pubmed.ncbi.nlm.nih.gov/36100355</a></p></li><li><p>Nie, X, et al., &amp; Wang, M (2023). Population pharmacokinetics of nalbuphine in patients undergoing general anesthesia surgery. <i>Frontiers in pharmacology</i> 14 1130287–None. DOI:<a href=\"https://doi.org/10.3389/fphar.2023.1130287\">10.3389/fphar.2023.1130287</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37025491/\">https://pubmed.ncbi.nlm.nih.gov/37025491</a></p></li><li><p>Lo, MW, et al., &amp; Whitney, CC (1987). The pharmacokinetics of intravenous, intramuscular, and subcutaneous nalbuphine in healthy subjects. <i>European journal of clinical pharmacology</i> 33(3) 297–301. DOI:<a href=\"https://doi.org/10.1007/BF00637566\">10.1007/BF00637566</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3691617/\">https://pubmed.ncbi.nlm.nih.gov/3691617</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Nalbuphine;
